1. First‐trimester enzyme exclusion of farber disease using a micromethod with [ 3 H]ceramide
- Author
-
X. D. Krasnopolskaya, V. S. Akhunov, and S. S. Gargaun
- Subjects
Male ,medicine.medical_specialty ,Ceramide ,Pathology ,Ceramides ,Tritium ,Amidohydrolases ,chemistry.chemical_compound ,Pregnancy ,Prenatal Diagnosis ,Internal medicine ,Ceramidases ,Genetics ,medicine ,Humans ,Genetics (clinical) ,chemistry.chemical_classification ,Farber disease ,Fetus ,business.industry ,Microchemistry ,Infant ,medicine.disease ,Ceramidase ,Pregnancy Trimester, First ,First trimester ,Enzyme ,Endocrinology ,medicine.anatomical_structure ,Chorionic Villi Sampling ,chemistry ,High specific activity ,embryonic structures ,Chorionic villi ,Female ,Chorionic Villi ,Lysosomes ,business - Abstract
Farber disease was diagnosed in a patient with typical features and ceramide accumulation in lipogranulomatous nodules. [3H]Ceramide with high specific activity was prepared and used to confirm diagnosis in the patient after her death and for prenatal studies in this family. A micromethod was developed for ceramidase assay in chorionic villi.
- Published
- 1994